These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38485084)

  • 1. A systematic review and meta-analysis of mortality in chronic Chagas cardiomyopathy versus other cardiomyopathies: higher risk or fiction?
    Gómez-Ochoa SA; Serrano-García AY; Hurtado-Ortiz A; Aceros A; Rojas LZ; Echeverría LE
    Rev Esp Cardiol (Engl Ed); 2024 Oct; 77(10):843-850. PubMed ID: 38485084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy.
    Martinelli Filho M; de Lima Peixoto G; de Siqueira SF; Martins SAM; Nishioka SAD; Pedrosa AAA; Teixeira RA; Dos Santos JX; Costa R; Kalil Filho R; Ramires JAF
    Europace; 2018 Nov; 20(11):1813-1818. PubMed ID: 29509903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta-analysis.
    Chadalawada S; Rassi A; Samara O; Monzon A; Gudapati D; Vargas Barahona L; Hyson P; Sillau S; Mestroni L; Taylor M; da Consolação Vieira Moreira M; DeSanto K; Agudelo Higuita NI; Franco-Paredes C; Henao-Martínez AF
    ESC Heart Fail; 2021 Dec; 8(6):5466-5481. PubMed ID: 34716744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic Profiling of End-Stage Heart Failure Secondary to Chronic Chagas Cardiomyopathy.
    Díaz ML; Burgess K; Burchmore R; Gómez MA; Gómez-Ochoa SA; Echeverría LE; Morillo C; González CI
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients.
    Drigo SA; Cunha-Neto E; Ianni B; Cardoso MR; Braga PE; Faé KC; Nunes VL; Buck P; Mady C; Kalil J; Goldberg AC
    Microbes Infect; 2006 Mar; 8(3):598-603. PubMed ID: 16427798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 10 Polymorphisms as Risk Factors for Progression to Chagas Disease Cardiomyopathy: A Case-Control Study and Meta-Analysis.
    Grijalva A; Gallo Vaulet L; Agüero RN; Toledano A; Risso MG; Quarroz Braghini J; Sosa D; Ruybal P; Repetto S; Alba Soto CD
    Front Immunol; 2022; 13():946350. PubMed ID: 35860267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S; Asad Z; Reynolds D
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 and fibrosis intensity in Chronic Chagas Cardiomyopathy: a systematic review.
    Chaves AT; Oliveira ALG; Guimarães NS; Magalhães IC; Menezes CADS; Rocha MODC
    Rev Inst Med Trop Sao Paulo; 2022; 64():e45. PubMed ID: 35749417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and mitochondria in the pathogenesis of chronic Chagas disease cardiomyopathy.
    Nunes JPS; Roda VMP; Andrieux P; Kalil J; Chevillard C; Cunha-Neto E
    Exp Biol Med (Maywood); 2023 Nov; 248(22):2062-2071. PubMed ID: 38235691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Progression to Chronic Chagas Cardiomyopathy: A Systematic Review and Meta-Analysis.
    Cutshaw MK; Sciaudone M; Bowman NM
    Am J Trop Med Hyg; 2023 Apr; 108(4):791-800. PubMed ID: 36848894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis.
    Ciapponi A; Barreira F; Perelli L; Bardach A; Gascón J; Molina I; Morillo C; Prado N; Riarte A; Torrico F; Ribeiro I; Villar JC; Sosa-Estani S
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008529. PubMed ID: 32804966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas Disease: A Systematic Review and Meta-analysis.
    Chadalawada S; Sillau S; Archuleta S; Mundo W; Bandali M; Parra-Henao G; Rodriguez-Morales AJ; Villamil-Gomez WE; Suárez JA; Shapiro L; Hotez PJ; Woc-Colburn L; DeSanto K; Rassi A; Franco-Paredes C; Henao-Martínez AF
    JAMA Netw Open; 2020 Aug; 3(8):e2015072. PubMed ID: 32865573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
    Akel T; Lafferty J
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is endothelial microvascular function equally impaired among patients with chronic Chagas and ischemic cardiomyopathy?
    Borges JP; Mendes FSNS; Lopes GO; Sousa AS; Mediano MFF; Tibiriçá E
    Int J Cardiol; 2018 Aug; 265():35-37. PubMed ID: 29753516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends in the contribution of Chagas cardiomyopathy to mortality among patients with heart failure.
    Nadruz W; Gioli-Pereira L; Bernardez-Pereira S; Marcondes-Braga FG; Fernandes-Silva MM; Silvestre OM; Sposito AC; Ribeiro AL; Bacal F; Fernandes F; Krieger JE; Mansur AJ; Pereira AC
    Heart; 2018 Sep; 104(18):1522-1528. PubMed ID: 29523589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.
    Freitas HF; Chizzola PR; Paes AT; Lima AC; Mansur AJ
    Int J Cardiol; 2005 Jul; 102(2):239-47. PubMed ID: 15982491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic Chagas disease.
    Vicco MH; Ferini F; Rodeles L; Cardona P; Bontempi I; Lioi S; Beloscar J; Nara T; Marcipar I; Bottasso OA
    Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):791-6. PubMed ID: 24773859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy.
    Martí-Carvajal AJ; Kwong JS
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009077. PubMed ID: 27388039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevalence of Atrial Fibrillation and Conduction Abnormalities in Chagas' Disease: A Meta-Analysis.
    Cardoso R; Garcia D; Fernandes G; He LI; Lichtenberger P; Viles-Gonzalez J; Coffey JO; Mitrani RD
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):161-9. PubMed ID: 26412204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis.
    Siddiqui WJ; Aggarwal S; Rafique M; Singh S; Kutalek S; Eisen HJ
    Heart Fail Rev; 2018 Mar; 23(2):181-190. PubMed ID: 29380177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.